Compare SPTX & EQBK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | SPTX | EQBK |
|---|---|---|
| Founded | 2024 | 2002 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.2B | 1.0B |
| IPO Year | 2026 | 2015 |
| Metric | SPTX | EQBK |
|---|---|---|
| Price | $18.60 | $47.07 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 8 | 7 |
| Target Price | $38.29 | ★ $56.86 |
| AVG Volume (30 Days) | ★ 155.6K | 71.1K |
| Earning Date | 11-05-2026 | 10-13-2026 |
| Dividend Yield | N/A | ★ 1.87% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 2.06 |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $30.59 |
| Revenue Next Year | N/A | $21.34 |
| P/E Ratio | ★ N/A | $23.01 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $17.59 | $38.60 |
| 52 Week High | $28.38 | $52.27 |
| Indicator | SPTX | EQBK |
|---|---|---|
| Relative Strength Index (RSI) | 44.86 | 31.36 |
| Support Level | $18.72 | $47.02 |
| Resistance Level | $22.75 | $48.80 |
| Average True Range (ATR) | 1.81 | 0.97 |
| MACD | -0.26 | -0.19 |
| Stochastic Oscillator | 32.71 | 11.08 |
Seaport Therapeutics Inc is a clinical-stage therapeutics company. The company focuses on invention and development of new medicines for patients with depression, anxiety, and other debilitating neuropsychiatric disorders. The company identified clinically validated mechanisms with established efficacy and safety profiles, historically limited by high first-pass metabolism, low bioavailability, and side effects. The company's pipeline products are based on Glyph, company's lymphatic-targeting prodrug technology is designed to bypass first-pass metabolism and thereby enhance a drug's oral bioavailability and reduce side effects.
Equity Bancshares Inc is a bank holding company. It provides a broad range of financial services to businesses and business owners as well as individuals through network of nearly 77 branches located in Arkansas, Kansas, Missouri and Oklahoma. The majority of the Company's revenues come from interest income on financial instruments, including loans, leases, securities and derivatives. The company also earns revenue from Non-interest income which includes Service charges and fees, Debit card income, Investment Referral Income, Trust Income and Insurance Sales Commissions.